Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-17

Clinical Trial Update: Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy, radiographic, and laboratory changes in refractory rheumatoid arthritis patients treated with Acthar Gel …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Iraj Sabahi Research Inc. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN